Renal Biomarkers Market | Leading Segments, Trends, Drivers and Challenges
Market Recovery and Growth Projections 2022-2026
Global renal biomarkers market is likely to post an incremental growth of $ 507.23 million, decelerating at a CAGR of 7.40% during the forecast period. This research provides a detailed analysis of the market segments and geographic landscape. It also offers insights into the various growth factors and challenges that are likely to have a negative impact on market growth. This thorough research will equip clients with the insights necessary to plan and strategize a post-pandemic recovery plan.
Request for Our Free Sample Report for detailed Insights
Renal Biomarkers Market: Market Segments and Growth Forecasts
This research report will provide insights into the current market share of each segment along with growth projections for the next five years.
- Market is segmented by End-user (Hospitals, Clinics and diagnostic laboratories, and Research laboratories) and Geography (North America, Europe, Asia, and ROW).
- 47% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Renal Biomarkers Market size.
Renal Biomarkers Market: Trends, Drivers, Challenges
The report also offers a detailed impact analysis of various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will equip clients to design a growth strategy for their business and area of operations.
- Rising prevalence of chronic kidney diseases will be a significant factor in driving the growth of the Renal Biomarkers Market.
- Increase in incidence of acute kidney injury (AKI) and associated risk factors will be instrumental in driving market growth during the forecast period.
- Limitations of and complications involved in renal biomarkers is a hurdle that needs to be crossed on the path to success.
Renal Biomarkers Market: Vendor Analysis
- The market is concentrated.
- Abbott Laboratories, bioMerieux SA, BioPorto AS, F. Hoffmann-La Roche Ltd., IQVIA Holdings Inc., Randox Laboratories Ltd., RenalSense Ltd., Siemens AG, SphingoTec GmbH, and Thermo Fisher Scientific Inc. are some of the major market participants.
- The unprecedented outbreak of COVID-19 in 2020 has had a significant impact on market segments had a ripple effect on various stakeholders. Our vendor analysis and insights will provide you with all the information required to make the most of the opportunities and plan business recovery and growth post the pandemic.
Key Areas Covered in our Report:
- Renal Biomarkers Market Split by End-user
- Hospitals
- Clinics and diagnostic laboratories
- Research laboratories
- Renal Biomarkers Market Split by Geography
- North America
- Europe
- Asia
- ROW
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- APAC - Market size and forecast 2020-2025
- MEA - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- North America - Market size and forecast 2020-2025
- South America - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Abbott Laboratories
- bioMerieux SA
- BioPorto AS
- F. Hoffmann-La Roche Ltd.
- IQVIA Holdings Inc.
- Randox Laboratories Ltd.
- RenalSense Ltd.
- Siemens AG
- SphingoTec GmbH
- Thermo Fisher Scientific Inc.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
Browse through some of our other related market research reports for more insights:
- Dialyzer Market: Technavio has been monitoring the dialyzer market and it is expected to grow by $ 3.36 billion, accelerating at a CAGR of almost 7% during the forecast period.
- Kidney Stones Market: The kidney stones market is expected to grow by $ 416.09 million, accelerating at a CAGR of almost 6.69% during the forecast period.
- Dialysis Disposable Devices Market: The Global dialysis disposable devices market is expected to grow by $ 1.62 billion, accelerating at a CAGR of 5.06% during the forecast period.
- Hemodialysis Catheters Market: The hemodialysis catheters market and it is expected to grow by $ 220.92 million, accelerating at a CAGR of almost 5.24% during the forecast period.
The report provides insights into the following FAQs:
- What is the market CAGR?
The market will decelerate at a CAGR of 7.40%.
- What is the incremental growth of the market?
The market is expected to grow by $ 507.23 mn through 2022-2026.
- What is a key factor driving this market?
Rising prevalence of chronic kidney diseases will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Europe, Asia, and ROW are the key regions featured in this research report.
- Which is the leading geographic region for this market:
47% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are Abbott Laboratories, bioMerieux SA, BioPorto AS, F. Hoffmann-La Roche Ltd., IQVIA Holdings Inc., Randox Laboratories Ltd., RenalSense Ltd., Siemens AG, SphingoTec GmbH, and Thermo Fisher Scientific Inc.
- What are the market segments covered in this report?
The market is segmented by End-user (Hospitals, Clinics and diagnostic laboratories, and Research laboratories) and Geography (North America, Europe, Asia, and ROW)
